Women’s perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru: a qualitative study

Table 1 The physical experience of pain as reported by women during and after ablative therapy

	During ablative therapy (N = 34^b)			Immediately after ablative therapy (N = 34^b)			Six weeks after ablative therapy (N = 28)
Pain score^a 0 (none)–10 (unbearable)	Mean	SD	Range	Mean	SD	Range	Mean	SD	Range
Pain score^a 0 (none)–10 (unbearable)	3.53	2.14	1–10	1.79	0.98	1–6	1.21	0.42	1–2

N number, SD standard deviation
^aAlthough our analog pain score was from 0 to 10 and some women explicitly mentioned in their interviews not having experienced pain during the TVT-TA procedure, no women reported a pain score of 0. See limitations section for possible explanations
^bTwo women who received TVT-TA did not report quantitative pain scores

ISSN: 1472-6874